“ironwood-pharmaceuticals” Archives

in
Entry Author Date Location
Protagonist Criss-Crosses Pacific, in Search of New Peptide Drugs 07/11/12 San Francisco
The Best Boring Companies in Biotech 07/09/12 National
Why Would a Biotech Company Go the Trouble of Changing Its Name? 06/04/12 National
T2 Nabs $23M, Ironwood Seeks IBS Drug Approval, FDA Sets Deadline for Alkermes Drug, & More Boston-Area Life Sciences News 08/12/11 Boston
Ironwood, Forest Seek FDA Approval 08/09/11 Boston
Gates Foundation Makes First Equity Investment in a Biotech Startup, Liquidia Technologies 03/08/11 Seattle
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Ironwood, One of the Big Boys Now, Strikes Deal With Tiny Protagonist Therapeutics 01/18/11 Boston
Ironwood Passes 4th Big Trial 11/01/10 Boston
Dana Farber Gets $33M from Sanofi, Astellas Backs DecImmune, Ironwood Sells Microbia, & More Boston-Area Deals News 09/29/10 Boston
Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News 09/24/10 Boston
Ironwood Pharmaceuticals Sells Struggling Microbia Subsidiary to Royal DSM 09/22/10 Boston
Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News 09/17/10 Boston
Venture-Backed IPOs Recovering but Weak: We Compare Results for San Francisco, Boston, Seattle, & San Diego 08/06/10 National
Venrock Raises $350M Fund 07/06/10 Boston
Three Ways To Make the Bay Area a More Stable Place for Innovation 06/14/10 San Francisco
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms 06/07/10 Boston
Is the Venture Model Really Broken? 05/12/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
Ironwood Pharma CEO Peter Hecht Breaks Silence on Company’s Big Biotech IPO 03/23/10 Boston
Aveo Pharmaceuticals Goes Public at $9, Falls Short of Hoped-For Range 03/11/10 Boston
MPM Collects $140M for Fifth Fund, NEXX Files for IPO, Nuance Advances on Mac Market, & More Boston-Area Deals News 02/17/10 Boston
Ironwood IPO Nets $203M Total 02/16/10 Boston
Ironwood Goes Public, Glasshouse and BG Medicine Aim to Do the Same, Vivox Collects $6.8M, & More Boston-Area Deals News 02/05/10 Boston
Ironwood Climbs 3.6 Percent on IPO Debut Day, Shows Investor Interest—Albeit Tepid—in Biotech 02/03/10 Boston
Ironwood Pharma IPO Price Cut Could Be Only Half the Story 02/03/10 Boston
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News 02/03/10 Boston
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry 02/01/10 Boston
Time Inc. Scoops Up StyleFeeder, Ironwood Sets Sights on Potential $266.7 M IPO, FloDesign Reveals $34.5M Financing, & More Boston-Area Deals News 01/22/10 Boston
Page 2 of 3 « previous page · next page »